DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cancer pharmacogenomics
Cancer pharmacogenomics
Pharmacogenomics to Predict Tumor Therapy Response: a Focus on ATP-Binding Cassette Transporters and Cytochromes P450
Somatic Pharmacogenomics in Cancer
A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients
Cancer Pharmacogenomics, Challenges in Implementation, and Patient-Focused Perspectives
CTGA 2014 Week 10
Role of Pharmacogenetics in Personalised Imatinib Dosing
Germline Variants in Cancer Therapy
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients
Pregnane X Receptor (PXR) Polymorphisms and Cancer
Discovering Long Noncoding RNA Predictors of Anticancer Drug Sensitivity Beyond Protein-Coding Genes
Pharmacogenomics in Oncology Care
Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic Response
Diverse Functions of DNA Methylation: Implications for Prostate Cancer and Beyond
Systematic Identification of Non-Coding Pharmacogenomic
Monoclonal Antibody Pharmacogenomics in Cancer Treatment
Tamoxifen Therapy and CYP2D6 Genotype
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: from Dose Puzzle to Pharmacogenomic Biomarkers
Top View
Evaluation of Personalized Medicine As Possible Therapeutical Approach in Oncology
Personalized Medicine: Studies of Pharmacogenomics in Yeast and Cancer
Transcriptionally Active Enhancers in Human Cancer Cells
Cancer Pharmacogenetics: Polymorphisms, Pathways and Beyond
Pharmacogenomics in Colorectal Cancer: Current Role in Clinical Practice and Future Perspectives
Genetic Markers of 5-Fluorouracil Associated-Toxicity in Colorectal Cancer Patients by Chenjie Zeng Dissertation Submitted to Th
The Synthetic Histone-Binding Regulator Protein Pctf Activates Interferon Genes in Breast Cancer Cells
Downloaded from the European Genome-Phenome Arch- Mab), and PI3K/AKT/Mtor (PAM; Ipatasertib, Everoli- Ive (EGAS00001002515)
(NGS): Revolutionizing Patient Care in Your Oncology Practice
Cancer Therapeutics in the ‘Omics’ Era Moving Towards Practical Application in the NHS
00001 1 2 3 4 5 6 7 8 9 10 Centers for Medicare and Medicaid
Emerging Epigenomic Landscapes of Pancreatic Cancer in the Era of Precision Medicine
Deep Learning in Pharmacogenomics: from Gene Regulation to Patient Stratification Alexandr A
Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation Andrew N
A Review of HER2-Directed Monoclonal Antibodies and Beyond ✉ Ricardo L
Plasma Imatinib Levels and ABCB1 Polymorphism Influences Early
Computational Analysis of Cis-Regulatory Mechanisms Underlying Cellular Response to Drug Perturbations
Pharmacogenomics in Oncology
Cancer Pharmacogenomics
Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation
Pharmacogenomics Influencing Drug-Gene Interactions Leading
Tumor-Derived Cell Lines As Molecular Models of Cancer Pharmacogenomics Andrew Goodspeed1, Laura M
Use of Pharmacogenetics for Predicting Cancer Prognosis and Treatment Exposure, Response and Toxicity